BP001830-PRO-634: Recombinant Human B-Cell Leukemia/Lymphoma 2 (-NWGR) Protein
Source: E. coli-derived.
Purity: > 95.0% as determined by(a) Analysis by RP-HPLC. (b) Analysis by SDS-PAGE.BP001830-PRO-632: Recombinant Human B-Cell Leukemia/Lymphoma 2 (-BH2) Protein
Source: E. coli-derived.
Purity: > 95.0% as determined by(a) Analysis by RP-HPLC. (b) Analysis by SDS-PAGE.BP001830-PRO-631: Recombinant Human B-Cell Leukemia/Lymphoma 2 (-BH1) Protein
Source: E. coli-derived.
Purity: > 95.0% as determined by(a) Analysis by RP-HPLC. (b) Analysis by SDS-PAGE.BP001830-PRO-630: Recombinant Human B-Cell Leukemia/Lymphoma 2 (BCL2) Protein
Source: E. coli-derived.
Purity: > 95.0% as determined by: (a) Analysis by RP-HPLC. (b) Analysis by SDS-PAGE.BP001827-PRO-450: Recombinant Human Annexin A9 (ANXA9) Protein
Source: E. coli-derived.
Purity: > 95.0% as determined by SDS-PAGE.BP001822-ALR-001: Recombinant Bee venom phospholipase A2 (PLA) Enzyme
Source: E. coli-derived.
Purity: > 90% pure as determined by 10% SDS-PAGE.BP001824-PRO-278: Recombinant Human Annexin A11 (ANXA11) Protein
Source: E. coli-derived.
Purity: > 95.0% as determined by SDS-PAGE.BP001825-PRO-765: Recombinant Human Annexin A3 (ANXA3) Protein
Source: E. coli-derived.
Purity: > 90% as determined by SDS-PAGE.BP001826-PRO-766: Recombinant Human Annexin A4 (ANXA4) Protein
Source: E. coli-derived.
Purity: > 90% as determined by SDS-PAGE.BP001818-PRO-1009: Recombinant Human ADP-Ribosylation Factor-Like 9 (ARL9) Protein
Source: E. coli-derived.
Purity: > 90.0% by SDS-PAGE.